3rd Jul 2018 10:47
LONDON (Alliance News) - Clinical-stage biopharmaceutical company Motif Bio PLC said Tuesday that Director Robert Bertoldi will resign from the board with effect on July 16.
Chief Executive Officer Graham Lumsden said: "On behalf of the board, we are grateful to Robert for his dedication and service to the company since its inception. We have appreciated his insight and wish him future success."
Motif Bio shares were trading were trading 1.9% lower at 33.10 pence each.
Related Shares:
MTFB.L